Heart rate recovery (HRR) after exercise is an independent predictor of adverse cardiovascular outcomes. HRR is mediated by both parasympathetic reactivation and sympathetic withdrawal and is highly heritable. We examined whether common genetic variants in adrenergic and cholinergic receptors and transporters affect HRR. In our study 126 healthy subjects (66 Caucasians, 56 African Americans) performed an 8 min step-wise bicycle exercise test with continuous computerized ECG recordings. We fitted an exponential curve to the postexercise R-R intervals for each subject to calculate the recovery constant (k r) as primary outcome. Secondary outcome was the root mean square residuals averaged over 1 min (RMS 1min), a marker of parasympathetic tone. We used multiple linear regressions to determine the effect of functional candidate genetic variants in autonomic pathways (6 ADRA2A, 1 ADRA2B, 4 ADRA2C, 2 ADRB1, 3 ADRB2, 2 NET, 2 CHT, and 1 GRK5) on the outcomes before and after adjustment for potential confounders. Recovery constant was lower (indicating slower HRR) in ADRA2B 301-303 deletion carriers (n ϭ 54, P ϭ 0.01), explaining 3.6% of the interindividual variability in HRR. ADRA2A Asn251Lys, ADRA2C rs13118771, and ADRB1 Ser49Gly genotypes were associated with RMS 1min. Genetic variability in adrenergic receptors may be associated with HRR after exercise. However, most of the interindividual variability in HRR remained unexplained by the variants examined. Noncandidate gene-driven approaches to study genetic contributions to HRR in larger cohorts will be of interest.
HEART RATE RECOVERY (HRR) following exercise, the gradual decrease in heart rate from peak exercise-induced tachycardia toward resting heart rate, predicts mortality independently of other cardiovascular risk factors both in patients with cardiovascular disease and in asymptomatic healthy subjects (6, 16, 33) . HRR after exercise is mediated by the interplay between the sympathetic and the parasympathetic limbs of the autonomic nervous system. After exercise, parasympathetic reactivation and sympathetic withdrawal both act to lower heart rate toward pre-exercise values (24) .
The extent and rate of HRR after exercise differ among individuals, and the mechanisms underlying these interindividual differences are not known. The heritability for HRR is considerable (estimated to be 0.34) (15) , suggesting that genetic factors contribute significantly to interindividual variability. However, there is little information about the specific genetic variants involved. Since sympathetic and parasympathetic mechanisms mediate HRR, functional genetic variation in these pathways may contribute to interindividual variability in HRR.
There are common functional variants in the genes encoding the ␤ 1 -(ADRB1) and ␤ 2 -adrenergic receptors (ARs) (ADRB2), which mediate the increase in heart rate in response to catecholamines (3, 4) . However, ADRB1 and ADRB2 variants were not associated with heart rate at 3 min after completion of a standardized exercise test (15) . The effects of variants in other candidate genes that affect sympathetic response on HRR have not been studied. In particular, functional genetic variants in ␣ 2 -adrenergic receptors (␣ 2 ARs) that regulate the sympathetic and the parasympathetic tone in the central nervous system (␣ 2A AR and ␣ 2C AR) (23, 32, 44, 45, 48) and variants in the norepinephrine transporter (NET), responsible for the rapid reuptake of norepinephrine from the synapse (13, 18, 19) , could affect HRR. Moreover, a functional variant in the G protein-coupled receptor kinase 5 (GRK5) affects ␤-AR-mediated signaling (25) .
Less is known about genetic variation in proteins regulating the parasympathetic nervous system and their functional effects. The choline transporter (CHT) mediates the reuptake of choline from the synaptic cleft into presynaptic cholinergic neurons of autonomic ganglia; this constitutes the rate-limiting step in the availability of acetylcholine in synaptic vesicles and may serve as a key regulator of parasympathetic tone (9, 34) . Mice that are genetically modified to have reduced expression of CHT have slower HRR after treadmill exercise (9) . Several genetic variants in human CHT have been characterized and are functional in vitro (35) . In addition, variant allele carriers of a CHT 3=-untranslated region polymorphism were reported to have a higher parasympathetic tone in vivo as determined by heart rate variability measures (31) . However, the effect of these genetic variants on parasympathetic tone during HRR is not known.
Thus, we addressed the hypothesis that common functional polymorphisms in candidate genes involved in regulation of adrenergic and cholinergic signaling (ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, NET, GRK5 and CHT) contribute to the interindividual variability in HRR and parasympathetic tone after exercise.
METHODS

Subjects
This study was approved by the Institutional Review Board of Vanderbilt University Medical Centre, Nashville, TN, and all subjects gave written informed consent. We studied 126 healthy subjects, taking no medications, all of whom also contributed data to previous studies (21) . Details of the subject recruitment are described elsewhere (19, 21) . In short, unrelated American white and black subjects residing in the Nashville area were eligible to participate if they fulfilled the following inclusion criteria: Aged between 18 and 50 yr, nonsmokers, and no clinically significant abnormality based on medical history, physical examination, electrocardiogram, and routine laboratory testing. Patients were free of medications for at least 1 wk and received a controlled alcohol-free and caffeine-free diet (providing 150 mmol of sodium, 70 mmol of potassium, and 600 mmol of calcium daily) for 6 days before the study. Each subject reported the intensity, duration, and frequency of his/her physical activity over the last 4 wk, and these data were converted into a measure of physical activity [metabolic equivalents (METS) * hour] using standard charts (1). The exercise score for each subject was defined as the mean number of METS*h/wk.
Protocol
On the morning (8:00 -10:00 AM) of the study day, subjects were admitted to a temperature-controlled room (22-23°C) . After 30 min of supine rest, subjects moved to a semirecumbent position on an adjacent electronically braked supine bicycle ergometer (ER 800L; Ergoline, Bitz, Germany). The exercise protocol consisted of biking at a constant rate (60 rpm) at sequentially increasing workloads of 25, 50, 75, and 100 W for 2 min each. A blood sample for the determination of plasma norepinephrine concentration was drawn immediately after peak exercise.
Genotyping
Subjects were genotyped for 21 variants in eight adrenergic and cholinergic pathway genes encoding receptors (6 variants in ADRA2A, 1 in ADRA2B, 4 in ADRA2C, 2 in ADRB1, and 3 in ADRB2), presynaptic transporters (2 variants each in CHT and NET), and one kinase (1 variant in GRK5, Table 1 ). These particular variants were chosen because they were either common [minor allele frequency (MAF) Ͼ5%], located in the coding or promoter region, or were shown to be functional in previous studies. To capture best genetic variability, markers within the same gene were chosen only if they were not in high linkage disequilibrium (r 2 Ն 0.80) in at least one of the races. Genotyping methods and quality control for variants in ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, NET, and GRK5 have been described previously (8, 19 -22, 30, 46) . ADRB2 rs1800888 (Thr164Ile) and two CHT variants [rs333229 (G/T) and rs1013940 (Ile89Val)] were genotyped in the Vanderbilt Center for Human Genetics Research DNA Resources Core by allelic discrimination with TaqMan 5=-nuclease assays (26) on an ABI 7900 HT real-time polymerase chain reaction system (Applied Biosystems, Foster City, CA) using validated TaqMan probes and a 95% quality value threshold (22) . Call rates ranged from 89.7 to 100.0%. For quality assurance, we repeated genotyping for 20% of the samples, yielding concordant results. 
Plasma Catecholamine Determination
Blood was collected in cooled heparin-coated tubes, which were immediately placed on ice until centrifuged at 4°C for 10 min at 3,000 rpm. Plasma was harvested and stored in tubes containing 40 l of reduced glutathione (6%) at Ϫ20°C until assayed. Norepinephrine and epinephrine concentrations were measured by high-performance liquid chromatography with electrochemical detection. Dihydroxybenzylamine was used as an internal standard (14) .
Measurements of HRR
After exercise, heart rate decreases from peak heart rate in an exponential manner. Several measures have been used to quantify HRR. The simplest measure is the absolute decrease in heart rate during the first minute after cessation of exercise (⌬HR 1min) (6, 16, 33) . This measure captures sympathetic withdrawal and parasympathetic reactivation during early recovery. However, since heart rate declines exponentially, ⌬HR 1min depends on the peak exercise heart rate achieved and is not an optimal marker to assess HRR during submaximal exercise.
An integrative measure of HRR during the whole recovery period is the recovery constant k r, representing the decay constant in the equation describing exponential decay (39) . This recovery constant is independent of the peak heart rate and equivalent to the elimination rate constant k e that describes the exponential decrease in plasma concentration over time of a drug with first-order pharmacokinetics. The recovery constant kr has been previously validated for the description of the exponential HRR after submaximal exercise (39), and we prospectively defined it as our primary outcome.
As a secondary outcome, we also assessed root mean square residuals (RMS), a validated marker of parasympathetic tone during recovery from exercise (11) . RMS measures the deviation of the R-R intervals from a straight line and thus is a measure of the typical oscillations of successive RR intervals, which reflect parasympathetic activity. At peak exercise, when vagal tone is very low, RMS is close to 0, but it rises quickly during the first minutes after cessation of exercise as vagal tone recovers.
Data Analysis and Statistics
Heart rate analyses from continuous ECG recordings were performed using customized software (Physiowave) written in PV-WAVE (Visual Numerics, Houston, TX) and MATLAB environments (Mathworks, Natick, MA). We used an algorithm described by Pan and Tompkins for QRS detection (36) . Additionally, we visually inspected all QRS detections to identify atrial and ventricular premature beats; R-R intervals preceding and following premature beats were removed from analysis.
We estimated the recovery constant k r for each subject after fitting an exponential curve to a graph of RR intervals over time, using y ϭ a*(1 Ϫ e Ϫkr*t ) ϩ c, where y represented R-R intervals (ms), a the magnitude of R-R interval changes, kr the recovery constant, t the time (s), and c the minimal R-R interval at peak exercise (Fig. 1) . Average heart rate and RMS values were calculated from R-R intervals over successive 30 s segments for the resting period (10 to 5 min before exercise), and during early recovery at 1 min after exercise (30 -90 s postexercise) (11) .
Normally distributed data were expressed as mean Ϯ standard deviation (SD) or 95% confidence interval. We used multiple linear regression models to analyze the effect of polymorphisms in adrenergic and cholinergic candidate genes on different prospectively defined measures of HRR (primary outcome, k r; secondary outcome, RMS1min). All models included as potential confounders age, sex, race, and exercise score.
We assumed an additive mode of inheritance, and genotypes were coded 0 -2 according to the number of variant alleles. We tested for Hardy-Weinberg equilibrium using 2 test with 1 degree of freedom.
Statistical analyses were performed using the statistical software STATA v. 10.0 (StataCorp, College Station, TX). All tests were two tailed, and P Ͻ 0.05 was considered significant. In this preliminary study, we did not adjust for multiple comparisons.
RESULTS
Subject Characteristics and Genotypes
The demographic characteristics, resting cardiovascular measures, and genotyping results for the 126 subjects (66 Caucasians and 56 African Americans; 70 women) are summarized in Tables 1 and 2 . All genotypes conformed to HardyWeinberg equilibrium in each ethnic group (all P Ͼ 0.05) except for the ADRA2A C-727G (rs2484516) variant in African Americans ( 2 ϭ 6.95, P ϭ 0.01) and ADRA2C del322-325 variant in Caucasians ( 2 ϭ 14.5, P Ͻ 0.001), a finding Fig. 1 . Representative heart rate recovery curve. For each subject, we fitted an exponential curve to the heart rate recovery curve, using y ϭ a*(1 Ϫ e Ϫkr*t ) ϩ c, where y represented R-R intervals (ms), a the magnitude of R-R interval changes, kr the recovery constant, t the time (s), and c the minimal R-R interval at peak exercise. possibly attributable to genetic admixture in African Americans and paucity of deletion allele carriers in Caucasians. Minor allele frequencies were in the expected range.
Exercise Test and HRR
Among 126 participants, 119 completed all four exercise stages up to 100 W, while seven subjects reached only 75 W and finished prematurely due to physical exhaustion. Mean peak exercise heart rate was 131.1 Ϯ 20.4 beats/min, and mean plasma NE concentration at peak exercise was 490 Ϯ 322 pg/ml. Results for the markers of HRR (k r and RMS 1min ) were within the previously reported range (Table 2) (7, 11).
Measures of HRR and Genotypes
Recovery constant k r . The ADRA2B 301-303 deletion was significantly associated with lower k r and, thus, slower HRR (Table 3 , Fig. 2 ). k r was 28.6% lower in ADRA2B 301-303 deletion homozygotes (n ϭ 12) than insertion homozygotes (n ϭ 65), with heterozygous subjects (n ϭ 42) having intermediate values (P ϭ 0.01, Fig. 2 ). This association remained significant after adjustment for age, sex, race, and exercise score in a multiple linear regression model (P ϭ 0.01, Table 3 ). Adding the 301-303 deletion variant to this linear regression model, with k r as dependent variable and age, sex, race, and exercise score as covariates, increased the coefficient of determination R 2 from 6.5 to 10.1% (P ϭ 0.01). Other covariates that were significantly associated with k r included race (P ϭ 0.02) and exercise score (P ϭ 0.04). A race-stratified sensitivity analysis showed that the association between k r and the del301-303 deletion was significant in Caucasians (P ϭ 0.02) but not in African Americans, likely because none of the deletion homozygotes were African American.
None of the other genetic variants was associated with k r . Similarly, k r was not associated with the peak norepinephrine concentrations at the end of exercise before or after adjustment for potential confounders like age, sex, race, and fitness (unadjusted P ϭ 0.35, adjusted P ϭ 0.84).
Measures of Parasympathetic Effects (RMS 1min )
None of the single nucleotide polymorphisms in the CHT gene was associated with RMS 1min . In contrast, variants in ADRA2A rs1800035 (Asn251Lys), ADRA2C rs13118771, and ADRB1 rs1801252 (Ser49Gly) were associated with higher RMS 1min (Table 3 , Fig. 3 ): compared with noncarriers, RMS 1min was 46% higher in carriers of one ADRA2A rs1800035 (Asn251Lys) allele (P ϭ 0.01 after adjustment for age, sex, race, and exercise score) and 26% higher in carriers of one ADRA2C rs13118771 allele (adjusted P ϭ 0.025). Similarly, subjects with two variants of ADRB1 rs1801252 had a 24% larger RMS 1min than subjects without any minor allele, with heterozygous subjects having intermediate values (adjusted P ϭ 0.005).
None of the other polymorphisms or other confounders was associated with RMS 1min before and after adjustment (all P Ͼ 0.34).
DISCUSSION
To our knowledge, this is the first study performed under highly controlled conditions to focus on the genetic contribution to HRR after exercise in healthy subjects. Our findings provide evidence that some genetic variants in the sympathetic pathway may be associated with HRR. A variant in ADRA2B was associated with slower HRR, while variants in ADRB1, ADRA2A, and ADRA2C were associated with higher RMS 1min , a marker of increased parasympathetic tone. However, associ- 
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HEART RATE RECOVERY AND AR GENE VARIANTS ations were generally weak, and the variants tested explained only a small proportion of the interindividual variability in HRR measures. Several studies have explored the genetic contribution to cardiovascular parameters during exercise (15, 41) ; however, little is known about the genetic contribution to HRR after exercise. A cross-sectional population study in the Framingham Offspring cohort examined the association of 235 variants in 14 candidate genes with cardiovascular parameters (blood pressure and heart rate) during exercise and recovery (15) . HRR was weakly associated with a variant in the ␣ 1B -AR. However, HRR was assessed by only one parameter (heart rate at 3 min after exercise). Moreover, candidate genes were selected focusing on regulation of blood pressure rather than of heart rate, and only two of the candidate genes in our study (encoding the ␤ 1 -and ␤ 2 -ARs) were included.
In our study, a number of variants in ␣ 2 -ARs, important regulators and mediators of sympathetic tone, were associated with HRR. A common deletion variant in the ␣ 2B AR was associated with a lower recovery constant and thus slower HRR after exercise. ␣ 2B AR is the major ␣ 2 -subtype mediating vasoconstriction in mice and most likely in humans (5, 17) . The ADRA2B del301-303 variant encodes a receptor that is markedly resistant to agonist-induced desensitization in vitro (43) and in vivo (29) , and this variant has been associated with higher resting sympathetic tone in healthy humans (47) . Thus, deletion allele carriers would be expected to have a higher sympathetic tone, compatible with our observation of slower HRR after exercise.
A number of genetic variants in ARs (e.g., in ADRA1A, ADRA2C del322-325, and ADRB2) (27, 28) have been associated with HRV at rest, but little is known about the effect of genetic variants on parasympathetic tone during recovery from exercise. We found three variants in adrenergic receptors [ADRB1 rs1801252 (Ser49Gly), ADRA2A rs1800035 (Asn251Lys), and ADRA2C rs13118771] to be associated with RMS 1min , a measure of parasympathetic tone, during the first minute of recovery. Parasympathetic and sympathetic pathways are directly linked (e.g., through inhibition of norepinephrine release from sympathetic neurons through presynaptic muscarinic receptors) and interact closely in the regulation of heart rate (2), but the functional level at which AR variants could affect vagal tone during HRR is unclear. Interestingly, in a previous study the Ser49 allele of ADRB1 (rs1801252) was associated with less heart rate reduction in response to the beta-blocker atenolol in healthy subjects (21) . ␣ 2A -ARs located in the central nervous system and presynaptically on sympathetic nerve terminals are regulators of both the sympathetic and the parasympathetic tone. Their activation results in inhibition of norepinephrine release into the synaptic cleft and thus a reduction in sympathetic tone (17, 38) . In addition, stimulation with clonidine, an agonist at the ␣ 2 -ARs, elicits a profound increase in cardiac parasympathetic activity (48) .
None of the CHT variants were associated with any of the HRR markers. However, the prevalence of the nonsynonymous rs1013940 variant, previously associated with a reduction of 50% in choline transport and the diagnosis of attention-deficit hyperactivity disorder (10) and major depression (12) , was low in our cohort (5%), and none of our subjects was homozygous for the variant allele.
The clinical significance of interindividual differences in HRR and parasympathetic tone has been explored by several recent clinical trials showing that these measures (assessed by ⌬HR and RMS) are independent predictors of cardiovascular mortality (6, 7, 16, 33, 40, 42, 49) . We studied healthy, comparatively young subjects; therefore, our findings cannot be automatically extrapolated to patients with cardiac disease. Future studies exploring the association of the genetic variants identified with HRR and cardiovascular morbidity and mortality in patients with heart disease will be of interest.
Our study had some limitations. Peak hearts were relatively low because we did not study HRR after maximum work capacity was reached and because bicycle ergometry produces lower heart rates when performed supine than when performed upright with the same exercise intensity (37) . However, using the recovery constant k r allows the assessment of HRR even without reaching maximal heart rate, and k r is more reliably derived after submaximal compared with maximal exercise (39) . The amount of self-reported physical exercise was only marginally associated with measures of HRR in our study. However, the majority of our subjects performed little or no physical exercise, and thus the range of physical fitness repre- Fig. 3 . Root mean square residuals at 1 min after exercise (RMS1min) and ADRA2A Asn251Lys, ADRA2C rs13118771, and ADRB1 Ser49Gly genotypes. The diamonds and the error bars represent means and SE, respectively. sented was small, reducing our chances to detect an association. Our study was exploratory, and in view of our sample size we did not perform statistical corrections for multiple comparisons. With this in mind, a post hoc power analysis revealed that our sample size (n ϭ 126) provided 91% power to detect a mean difference of 0.006 in the recovery constant k r (corresponding to 75% of its SD) between carriers and noncarriers of a polymorphism with an MAF of at least 0.1 (␣ ϭ 0.05). Similarly, our study design had the advantage of studying a relatively homogenous cohort under closely controlled conditions, but the relatively small sample size limited power to detect small genotype effects, especially for less common variants. Thus, we cannot exclude the possibility that some of the variants had smaller effects on the outcomes that we did not detect. The sample size also provided only limited power for separate race-specific analyses. However, sensitivity analyses in racial subgroups generally showed effects of similar magnitude and similar trends when the variants were prevalent enough in both races. Moreover, combined analyses of genetically diverse ethnic subgroups may be helpful in identifying truly causal variants rather than markers merely associated with causal variants by linkage disequilibrium (50) . In this preliminary study, our objective was to identify markers that substantially contribute to the population variability in HRR; we therefore studied only common (MAF Ͼ 5%) or functional polymorphisms in candidate genes associated with sympathetic and cholinergic pathways. Substantially larger cohorts would be necessary to fully cover genetic diversity in these candidate genes (by haplotype analyses) or for a noncandidate driven, systematic approach (e.g., genome-wide association studies).
In conclusion, this exploratory, candidate-gene approach to the study of genetic contribution to HRR provides evidence for an association of variants in ARs with measures of HRR and parasympathetic tone after exercise. However, most of the interindividual variability in HRR remained unexplained. Future studies in larger samples are necessary to validate our results, define additional genetic markers, and extrapolate our findings to patients with heart disease in order to examine the predictive value of the identified markers for cardiovascular morbidity and mortality. 
